Markers of Prognosis and Response to Therapy in Patients With Metastatic Brain Tumors Undergoing Stereotactic Radiosurgery (SRS)
Metastatic Brain Tumor
Conditions: official terms
Brain Neoplasms
Conditions: Keywords
Sterotactic Radiosurgery
Study Type
Observational [Patient Registry]
Study Phase
Study Design
Time Perspective: Prospective
Overall Status
This registry study will evaluate patients with metastatic brain tumors undergoing, or having undergone, stereotactic radiosurgery (SRS) at Swedish Medical Center. Clinical outcomes will be evaluated at the 3, 6 and 12-month time points. Clinical data, SRS treatment data, and imaging data (including anatomic and advanced imaging sequences obtained prior to and serially following SRS) will be archived in an online informatics platform, specifically a metastatic brain tumor registry known as the Comprehensive Neuro-oncology Data Repository for Metastatic Tumors (CONDR - Mets).
Criteria for eligibility
Healthy Volunteers: No
Maximum Age: 80 Years
Minimum Age: 19 Years
Gender: Both
Criteria: Inclusion Criteria:

- Adult patients (>18 yo) with a pathological diagnosis of metastatic brain cancer

- Participants must have >4 tumors felt to require stereotactic radiosurgery

- Karnofsky scale of > 70 at the time of initial treatment

- Age < 80

Exclusion Criteria:

- Karnofsky scale <70

- Age > 80

- Inability to undergo MR imaging studies
Swedish Medical Center
Seattle, Washington, United States
Status: Recruiting
Contact: Tracie Granger - 206-215-2466 -
Start Date
January 2013
Swedish Medical Center
Swedish Medical Center
Record processing date processed this data on July 28, 2015 page